With a handful of publicly-traded cannabis companies set to present at the upcoming Spring Investor Summit in New York City, we wanted to give investors a heads up on which companies are worth keeping an eye on ahead of time.
What is the Spring Investor Summit?
Set to take place at the Essex House overlooking Central Park, the Spring Investor Summit’s focus is to highlight the most compelling publicly-traded companies under $5 billion in market cap across all sectors. The upcoming event on April 1st and 2nd, 2019 will feature 200 presenting companies, 1200 institutional & retail investors, 2000 one-on-one meetings, and an assortment of industry panels. And, while the Spring Investor Summit is exclusive and private, it is totally free for qualified investors.
10+ Cannabis Companies Expected to Present
Out of 200 companies expected to present, eleven of them are cannabis-related. Out of those eleven, ten of them are publicly-traded, and the other one is expected to be in the near future. It can be very important to be aware of when and where any of your current or prospective portfolio holdings are presenting or participating in conferences.
First and foremost, the increased awareness garnered by these conferences can move stock prices. Secondly, the companies participating usually have some of their top executives giving an overview of their company and what’s to come.
Australis Capital Inc. identifies and invests in the cannabis industry predominately in the United States, a highly regulated, fragmented, rapidly expanding and evolving industry. Investments may include and are not limited to equity, debt or other securities of both public and private companies, financings in exchange for royalties or other distribution streams, and control stake acquisitions.
Recently, Australis Capital’s Chief Financial Officer attended and met with investors at the ROTH Conference 2019.
Cannex Capital Holdings Inc. was founded in 2017 and is managed by a team of experienced industry and capital markets experts who are committed to aggressive, cost-effective growth. Cannex intends to facilitate growth through cash flow from operations, strategic acquisitions, and partnerships and by leveraging the expertise of its experienced operational team.
Recently, Cannex Capital Holdings signed a binding letter agreement to acquire 100% of San Diego, California based Pure Ratios Holdings, Inc., in a cash and stock transaction.
High Times (PRIVATE)
High Times, which is expected to go public following the completion of its current Reg A+ offering round, is arguably the most recognized name in the entire marijuana industry. From its iconic magazines to its memorable events, High Times generates millions in revenues.
Recently, Hightimes Holding Corp., the parent company of High Times, announced its plans to acquire the assets and events business of Feria Del Canamo, S.L., doing business as Spannabis.
Indiva Limited is a Canadian licensed producer and supplier of high quality, medical grade cannabis. INDIVA’s strain selection, cultivation, and client care processes combine the know-how and experience of an internationally recognized and award-winning grow-team with GMP-compliant quality assurance standard operating procedures.
Recently, Indiva raised millions of dollars in growth capital via a bought deal offering with Eight Capital.
InMed Pharmaceuticals Inc. is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary bioinformatics database drug/disease targeting tool, cannabinoid biosynthesis technology, and drug development pipeline are the fundamental drivers of shareholder value.
Marrone Bio Innovations, Inc. is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Just recently, Marrone Bio Innovations announced that three MBII active ingredients are now legal for use on cannabis crops in the California cultivation market.
Recently, Marrone Bio Innovations released financial results for the fourth quarter and full year ended December 31, 2018.
Medicine Man Technologies Inc. is a fully integrated operator in the cannabis industry, offering consulting, retail pharma-grade products, and turnkey solutions for cannabis cultivators for over a decade. Medicine Man Technologies is leveraging its expertise and intellectual property to vertically integrate retail, cultivation, formulation, and distribution operations. Medicine Man Technologies’ client portfolio includes active and past clients in 18 states and seven countries.
Recently, Medicine Man presented at the second annual LD Micro Virtual Conference.
Nemus Bioscience, Inc. is a biopharmaceutical company, headquartered in Long Beach, California, focused on the discovery, development, and commercialization of bioengineered cannabinoid-based therapeutics for significant unmet medical needs in global markets. With proprietary technology licensed from the University of Mississippi, Nemus is developing novel ways to deliver cannabinoid-based drugs for specific indications with the aim of optimizing the clinical effects of such drugs while limiting potential adverse events.
Recently, Nemus Bioscience CEO and Chief Medical Officer Dr. Brian Murphy presented in a panel discussion, “Cannabinoid Pharmaceuticals,” at the 31st Annual ROTH Conference.
NexTech AR Solutions Corp. is bringing augmented reality to the masses by creating an AR ecosystem featuring eCommerce solutions for websites, AR learning, and education, as well as AR, live streaming for events. The company has filed a patent around its AR web-enabled eCommerce platform which has been integrated with Shopify, WordPress, and Magento. In the marijuana industry, NexTech AR Solutions is working with Cannvas MedTech Inc. (CSE:MTEC) (OTC:CANVF) (FRA:3CM) to leverage augmented reality technology for cannabis education technology.
And, recently, NexTech AR Solutions Corp. signed an LOI to acquire an eCommerce business that generated $2.2 million USD in revenue and $600,000 in EBITDA in 2018, for the cash purchase price of $1,850,000 USD.
Rocky Mountain High Brands, Inc. is a fully reporting lifestyle brand management company specializing in high-quality hemp and CBD health and wellness beverages and products. Rocky Mountain’s brands include HEMPd, Eagle Spirit and more.
Recently, Rocky Mountain High Brands entered into an exclusive Beverage Manufacture and Supply Agreement with Texas Wellness Center, LLC, a marketer and distributor of hemp and CBD products under the Green Lotus brand.
Valens GroWorks Corp. is a vertically integrated provider of Canadian cannabis products developed from our proprietary extraction techniques, with three wholly-owned subsidiaries located in and around Kelowna, BC. Subsidiary Valens Agritech, a.k.a. VAL, holds a license to cultivate and produce oil as a Licensed Producer under the ACMPR, and a Dealer’s License under Health Canada.
Recently, Valens GroWorks reported financial results for its 2018 fiscal year ended November 30, 2018.
Zenabis Global Inc. through its subsidiaries, is a licensed producer and seller of medical and recreational cannabis. It has facilities in New Brunswick, Nova Scotia and British Columbia. It also supplies propagated vegetable and bedding plants from its facilities in Pitt Meadows and Langley, British Columbia.
Earlier this week, Zenabis Global Inc. signed its first exclusive, definitive supply agreement under its Zen Craft Grow program.
Since there’s still a bit of time between now and the conference, there still may be other cannabis companies joining the roster to present. In the meantime, be sure to subscribe to updates here so you never miss an important development.
Get Real-Time Updates from The Daily Marijuana Observer